Literature DB >> 7683772

Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria.

M Hide1, D M Francis, C E Grattan, J Hakimi, J P Kochan, M W Greaves.   

Abstract

BACKGROUND: Most urticarias are induced by vasoactive mediators such as histamine released from mast cells. Although mast cells are activated by allergens through cross-linking of cell-surface--bound IgE, this mechanism does not appear to explain most cases of chronic urticaria, which, when allergic, infectious, drug-induced, or physical causes cannot be identified, are classified as idiopathic.
METHODS: We recruited 26 patients with chronic idiopathic urticaria, in whom intradermal injection of autologous serum caused a wheal-and-flare response. Serum from four patients that induced marked histamine release from basophils from a donor with very low serum IgE levels was studied with respect to the IgE dependence of the histamine release, the activity of the IgG fractions, and the neutralizing effect of a recombinant preparation of the soluble extracellular domain of the alpha subunit of the high-affinity IgE receptor (sFc epsilon RI alpha).
RESULTS: The histamine-releasing activity of the serum was abolished by passive sensitization of basophils with myeloma IgE, enhanced after dissociation of IgE by treatment with lactic acid, and induced by IgG fractions from the serum of all four patients. Preincubation of the serum and isolated IgG with sFc epsilon RI alpha resulted in almost complete neutralization.
CONCLUSIONS: Histamine-releasing IgG autoantibodies against the alpha subunit of the high-affinity IgE receptor are present in the circulation of some patients with chronic urticaria. Autoantibody-induced cross-linking of IgE receptors may be an important mechanism in the pathogenesis of chronic urticaria and other diseases mediated by mast cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683772     DOI: 10.1056/NEJM199306033282204

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  140 in total

1.  [Autoreactive urticaria and autoimmune urticaria].

Authors:  M Maurer; M Metz; M Magerl; F Siebenhaar; P Staubach
Journal:  Hautarzt       Date:  2004-04       Impact factor: 0.751

Review 2.  Chronic urticaria and thyroid auto-immunity.

Authors:  Marie-Sylvie Doutre
Journal:  Clin Rev Allergy Immunol       Date:  2006-02       Impact factor: 8.667

Review 3.  Eosinophils and urticaria.

Authors:  Delphine Staumont-Sallé; David Dombrowicz; Monique Capron; Emmanuel Delaporte
Journal:  Clin Rev Allergy Immunol       Date:  2006-02       Impact factor: 8.667

Review 4.  Chronic spontaneous urticaria: an autoimmune disease? A revision of the literature.

Authors:  Gabriele Di Lorenzo; Maria Stefania Leto-Barone; Simona La Piana; Aurelio Seidita; Giovam Battista Rini
Journal:  Clin Exp Med       Date:  2012-05-15       Impact factor: 3.984

Review 5.  Chronic Spontaneous Urticaria: The Devil's Itch.

Authors:  Sarbjit S Saini; Allen P Kaplan
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jul - Aug

Review 6.  Targeting the Fc receptor in autoimmune disease.

Authors:  Xinrui Li; Robert P Kimberly
Journal:  Expert Opin Ther Targets       Date:  2014-03       Impact factor: 6.902

7.  Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders.

Authors:  Christine B Cho; Shahan A Stutes; Michelle L Altrich; Stacy P Ardoin; Gary Phillips; Princess U Ogbogu
Journal:  Ann Allergy Asthma Immunol       Date:  2013-01       Impact factor: 6.347

Review 8.  Autoimmune urticaria.

Authors:  Malcolm Greaves
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

Review 9.  Evaluating chronic urticaria patients for allergies, infections, or autoimmune disorders.

Authors:  Y C Wai; Gordon L Sussman
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

Review 10.  Histopathology of chronic urticaria.

Authors:  G Edward Stewart
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.